Landmark Clinical Trial of a Novel Combination Treatment for Type 1 Diabetes Begins at Jewish General Hospital and McGill University Health Centre

Classified as: muhc, jewish general hospital, diabetes, insulin, McGill University Health Centre, health and lifestyle, blood sugar, glucose, type 1, beta cells, EVMS, Jerry Nadler, INGAP peptide
Published on: 25 Nov 2015
Back to top